MAPT and Alzheimer disease: The neurodegenerative processes that lead to AD remain to be fully understood and although the accumulation of Aβ and hyper-phosphorylated Tau protein have a key role, investigating the relevant cellular pathways that are impaired in the early stages of the disease process is required.